Showing 3641-3650 of 7016 results for "".
The Scientific Pursuit of More Precise Care
https://reachmd.com/programs/heart-matters/the-scientific-pursuit-of-more-precise-care/4790/Patient-centered care is a hot topic in health care these days, though usually when we think of patient-centeredness, our thinking tilts toward aspects of policymaking or system delivery. Host Dr. Janet Wright takes a look at the science side of patient-centered care — the more precise tailoring ofDiagnosing Non-Arthritic Hip Pain in Athletes
https://reachmd.com/programs/focus-on-sports-medicine/diagnosing-non-arthritic-hip-pain-in-athletes/3800/In sports medicine, the hip has traditionally received less attention from physicians than other joints. What are the types of non-arthritic hip pain that clinicians need to recognize in order to make accurate diagnoses for both recreational and professional athletes? Dr. Brian Kelly, assistant profWho was John Gofman?
https://reachmd.com/programs/lipid-luminations/who-was-john-gofman/2029/Dr. Larry Kaskel welcomes Dr. Virgil Brown to Lipid Luminations. Dr. William Virgil Brown, Editor-in Chief of the Journal of Clinical Lipidology and Charles Howard Candler Professor of Medicine at Emory University School of Medicine. Tune in to hear about neclear physicist, John Gofman and the majorVNS: Beyond Seizure Control
https://reachmd.com/programs/cme/vns-beyond-seizure-control/35795/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care
https://reachmd.com/programs/cme/interdisciplinary-strategies-for-brca-mutated-ebc-testing-targeting-and-team-based-care/36606/Explore genetic testing, clinical trial evidence, and team-based strategies for managing patients with high-risk BRCA-mutated early-stage breast cancer.Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
https://reachmd.com/programs/cme/clinical-evidence-insights-from-early-trials-of-cdh6-targeted-therapies/37669/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerUnderstanding Endocrine Resistance in HR+/HER2- mBC
https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.What Are the Latest Advances in Lupus Care?
https://reachmd.com/programs/conference-coverage/what-are-the-latest-advances-in-lupus-care/10308/Although nonrenal lupus patients face a variety of challenges, there’s fortunately been a lot of advances in care, as outlined by a guru in lupus.PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
https://reachmd.com/programs/cme/PI3K-Pathway-inhibition-in-HR-HER2-mBC-Mechanistic-Insights/37329/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Updates to the Diagnostic Criteria for MS Patients
https://reachmd.com/programs/neurofrontiers/updates-to-the-diagnostic-criteria-for-ms-patients/26379/What are the updates for MS patients?